Latest Capital Raises News

Great Divide Mining has transitioned its Challenger Gold Mine in NSW from commissioning to commercial production, targeting a gold concentrate grade of 30 grams per tonne from historic tailings with minimal capital expenditure.

Hiremii Limited has delivered its most profitable quarter yet, reporting record revenue and gross profit alongside its first positive adjusted EBITDA. The company also secured its first recurring SaaS contracts, marking a milestone in its shift towards a technology-driven workforce intelligence model.

KMD Brands has secured NZ$11 million from its retail entitlement offer, with a 52% participation rate. The company now moves to clear a 169 million share shortfall through a retail bookbuild, while shares remain halted ahead of trading resumption.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

MA Credit Income Trust has approved an on-market buy-back of its units, adding a flexible tool to its capital management arsenal amid evolving market conditions.

Cosmo Metals is gearing up for a significant drilling campaign at its Kanowna Gold Project near Kalgoorlie, while systematic exploration at its NSW projects has revealed two high-priority copper-gold VMS targets. The company also bolstered its balance sheet with a $1.55 million entitlement offer to fund ongoing work.

BPM Minerals has reported compelling high-grade gold assay results from maiden drilling at its Beachcomber Prospect and secured A$3.5 million in a strategic placement to fund an expanded 2026 exploration campaign across its Forelands Gold Project.

AnteoTech (ASX: ADO) pushed forward its advanced battery and life sciences technologies in the March 2026 quarter, achieving key product validations and expanding its sales pipeline to record levels. The company ended the period with A$3.3 million cash and no debt following a recent A$3.5 million capital raise.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

MyEco Group has locked in $0.92 million through its Series 2 convertible note program, reinforcing its growth trajectory with funding earmarked for a new GRS-certified recycled bin liner range. The raise supplements a solid cash position while aiming to limit shareholder dilution amid challenging market conditions.

Kinetiko Energy is advancing a staged development strategy to unlock its 6 trillion cubic feet gas resource in South Africa, targeting first revenues within 18 months through a capital-efficient, risk-managed approach.